
Keywords: children; fatal outcome; febrile ulceronecrotic Mucha-Habermann disease; ABS; antibiotics; DDS; diamino-diphenyl sulphone; FUMHD; Febrile ulceronecrotic Mucha-Habermann disease; IVIG; intravenous immunoglobulins; MI; mucosal involvement; MTX; methotrexate